09:23:07 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Emerald Health Therapeutics Inc
Symbol EMH
Shares Issued 136,997,693
Close 2018-12-07 C$ 2.77
Market Cap C$ 379,483,610
Recent Sedar Documents

Emerald Health closes $10.8M prospectus sale of shares

2018-12-07 18:30 ET - News Release

Mr. Rob Hill reports

EMERALD HEALTH THERAPEUTICS CLOSES $10.8 MILLION PROSPECTUS SALE

Emerald Health Therapeutics Inc. closed today its prospectus sale to a single Canadian institutional accredited investor announced on Dec. 3, 2018. Pursuant to the offering, the company has issued four million common shares of the company at a price per common share of $2.70 for gross proceeds of $10.8-million.

The investor has an option to acquire up to a maximum of 1,555,555 additional common shares at a price per common share of $2.70 for a period of 10 business days from the closing date. This option was increased from the previously announced 600,000 common shares. Complete exercise of the option would add gross proceeds of $4.2-million.

The company intends to use the net proceeds of the offering to finance the completion of capital projects, research and development, working capital, and general corporate purposes.

The common shares were offered by way of a shelf prospectus supplement filed in all of the provinces of Canada, except Quebec, pursuant to National Instrument 44-101, Short Form Prospectus Distributions, and National Instrument 44-102, Shelf Distributions.

About Emerald Health Therapeutics Inc.

Emerald Health is a Canadian licensed producer of cannabis. Its 50-per-cent-owned Pure Sunfarms joint venture in British Columbia is completing the conversion of its 1.1-million-square-foot (25-acre) greenhouse in the Lower Mainland to cultivate cannabis and its Agro-Biotech operation in Quebec is currently operating out of its 75,000-square-foot indoor cannabis cultivation facility. Commercial production is expanding in both facilities.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.